Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Immunology|October 9, 2012
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosisF Sellebjerg, M Krakauer, M Khademi, et al.
European Journal of Neurology|July 20, 2004
Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosisT L Sørensen, R M Ransohoff, R M Strieter, et al.
European Journal of Neurology|May 9, 2012
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patientsP E H Jensen, F Sellebjerg, H B Søndergaard, et al.
Multiple Sclerosis and Related Disorders|May 12, 2021
Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseasesN R Oksbjerg, S D Nielsen, M Blinkenberg, et al.
Journal of Neuroimmunology|August 4, 1998
Soluble ICAM-1, demyelination, and inflammation in multiple sclerosis and acute optic neuritisA A Petersen, F Sellebjerg, J Frederiksen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosisF Sellebjerg, C V Jensen, H B W Larsson, et al.
Journal of Neuroimmunology|January 8, 2000
CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosisF Sellebjerg, H O Madsen, C V Jensen, et al.
Acta Neurologica Scandinavica|December 23, 2017
Bone microarchitecture and bone mineral density in multiple sclerosisA Olsson, A B Oturai, H B Søndergaard, et al.
Annals of Neurology|December 1, 1995
Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA systemF Sellebjerg, H O Madsen, J L Frederiksen, et al.
Pageof 10